Validation and update of a multivariable prediction model for the identification and management of patients at risk for hepatocellular carcinoma
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Validation and update of a multivariable prediction model for the identification and management of patients at risk for hepatocellular carcinoma
Authors
Keywords
-
Journal
Clinical Proteomics
Volume 18, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-08-19
DOI
10.1186/s12014-021-09326-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma
- (2021) Honglei Feng et al. BMC CANCER
- Hepatocellular carcinoma demonstrates heterogeneous growth patterns in a multi‐center cohort of patients with cirrhosis
- (2020) Nicole E. Rich et al. HEPATOLOGY
- Validation and Utility Testing of Clinical Prediction Models
- (2020) Amin Adibi et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Modeling the time-related fluctuations of AFP and PIVKA-II serum levels in patients with cirrhosis undergoing surveillance for hepatocellular carcinoma
- (2020) Gabriele Ricco et al. Cancer Biomarkers
- Continued value of the serum alpha-fetoprotein test in surveilling at-risk populations for hepatocellular carcinoma
- (2020) Jihyun An et al. PLoS One
- Validation of a novel model for the early detection of hepatocellular carcinoma
- (2019) Philip M. Hemken et al. Clinical Proteomics
- Surveillance for Hepatocellular Carcinoma: Current Best Practice and Future Direction
- (2019) Fasiha Kanwal et al. GASTROENTEROLOGY
- Predicting 1‐Year Mortality in Older Hospitalized Patients: External Validation of the HOMR Model
- (2019) Denis Curtin et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Hepatocellular carcinoma surveillance: An evidence-based approach
- (2019) Patrick S Harris et al. WORLD JOURNAL OF GASTROENTEROLOGY
- REAL-B (Real-world Effectiveness from the Asia Pacific Rim Liver Consortium for HBV) Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated with Oral Antiviral Therapy
- (2019) Hwai-I Yang et al. JOURNAL OF INFECTIOUS DISEASES
- Diagnostic value of gamma-glutamyltransferase/aspartate aminotransferase ratio, protein induced by vitamin K absence or antagonist II, and alpha-fetoprotein in hepatitis B virus-related hepatocellular carcinoma
- (2019) Qiang Wang et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Three myths about risk thresholds for prediction models
- (2019) Laure Wynants et al. BMC Medicine
- A Novel Online Calculator Based on Serum Biomarkers to Detect Hepatocellular Carcinoma among Patients with Hepatitis B
- (2019) Tian Yang et al. CLINICAL CHEMISTRY
- Calibration: the Achilles heel of predictive analytics
- (2019) Ben Van Calster et al. BMC Medicine
- Reassessing the accuracy of PAGE-B-related scores to predict hepatocellular carcinoma development in patients with chronic hepatitis B
- (2019) Terry Cheuk-Fung Yip et al. JOURNAL OF HEPATOLOGY
- Clinical utility of hepatocellular carcinoma risk scores in chronic hepatitis B
- (2019) Thodoris Voulgaris et al. LIVER INTERNATIONAL
- Diagnosis, Staging and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
- (2018) Jorge A. Marrero et al. HEPATOLOGY
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2018) Peter R. Galle et al. JOURNAL OF HEPATOLOGY
- Reporting and Interpreting Decision Curve Analysis: A Guide for Investigators
- (2018) Ben Van Calster et al. EUROPEAN UROLOGY
- Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
- (2017) Masao Omata et al. Hepatology International
- First things first: risk model performance metrics should reflect the clinical application
- (2017) Kathleen F. Kerr et al. STATISTICS IN MEDICINE
- Cost-Effectiveness of Risk Score–Stratified Hepatocellular Carcinoma Screening in Patients with Cirrhosis
- (2017) Nicolas Goossens et al. Clinical and Translational Gastroenterology
- Assessing the Clinical Impact of Risk Prediction Models With Decision Curves: Guidance for Correct Interpretation and Appropriate Use
- (2016) Kathleen F. Kerr et al. JOURNAL OF CLINICAL ONCOLOGY
- A closed testing procedure to select an appropriate method for updating prediction models
- (2016) Yvonne Vergouwe et al. STATISTICS IN MEDICINE
- Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD)
- (2015) Gary S. Collins et al. ANNALS OF INTERNAL MEDICINE
- Diagnostic Delays Are Common Among Patients With Hepatocellular Carcinoma
- (2015) Nishant Patel et al. Journal of the National Comprehensive Cancer Network
- Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients
- (2015) Tae Seop Lim et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Towards better clinical prediction models: seven steps for development and an ABCD for validation
- (2014) E. W. Steyerberg et al. EUROPEAN HEART JOURNAL
- Calibration of Risk Prediction Models
- (2014) Ben Van Calster et al. MEDICAL DECISION MAKING
- α-Fetoprotein, Des-γ Carboxyprothrombin, and Lectin-Bound α-Fetoprotein in Early Hepatocellular Carcinoma
- (2009) Jorge A. Marrero et al. GASTROENTEROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now